Clinical Trials Directory

Trials / Completed

CompletedNCT03153943

HIP Mobile: A Community-based Monitoring, Rehabilitation and Learning e-System for Patients Following a Fracture

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Approximately 30,000 adults in Quebec over the age of 50 suffer a fragility fracture each year. Fractures can affect a person's health, well-being and autonomy. Personal costs of these fractures are high, with as many as 50% of hip fracture patients being unable to return their pre-fracture level of autonomy. Homecare and community services provide customary rehabilitation support immediately following discharge from acute-care, though this contribution can be limited by lack of resources. For those patients at risk of negative outcomes, we have demonstrated clinically important benefits of extended exercise rehabilitation programs offered beyond the regular rehabilitation period on improving physical function. Through advances in sensor and telecommunication technology, eHealth solutions incorporated within homecare services as an integral part of the continuum of care can lead to better patient and health professional experience, improve clinical outcomes and reduce costs to the healthcare system. The purpose of this study is to determine if the implementation of a 3-month community-based extended-rehabilitation e-Monitoring and Coaching support program is more effective at improving mobility in community-dwelling elderly patients who have sustained a fracture than a printed material support program, and if these effects persist 6 months after discontinuation.

Conditions

Interventions

TypeNameDescription
DEVICEHIP Mobile e-Monitoring support3-month community-based extended-rehabilitation e-Monitoring and Coaching support program
OTHERWorkbook supportPrinted material support

Timeline

Start date
2017-03-29
Primary completion
2021-01-22
Completion
2021-01-22
First posted
2017-05-15
Last updated
2021-09-01

Locations

3 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT03153943. Inclusion in this directory is not an endorsement.